MTOR and cancer: Several mTOR inhibitors have been approved for cancer treatment; however, concerns regarding their immunosuppressive properties have emerged.35 Studies have shown that mTOR inhibitors can impair T-cell activation and proliferation by decreasing the production of cytokines and growth factors essential for T-cell function and differentiation.